Release Date: 31/08/16 14:32 Summary: Preliminary Final Report-EVM.AX Price Sensitive: No Download Document 148.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%